Literature DB >> 31804760

Quercetin alleviates lipopolysaccharide-induced inflammatory responses by up-regulation miR-124 in human renal tubular epithelial cell line HK-2.

Shuxia Guo1, Juanjuan Sun1, Yan Zhuang1.   

Abstract

Chronic kidney disease (CKD) is a persistent kidney structural and functional disorder. Quercetin is one of active extracted flavonoids and has protective effects. Therefore, we proposed to survey the effect of Quercetin on CKD. HK-2 cells were preprocessed by Quercetin and then irritated with lipopolysaccharide (LPS). CCK-8 assay and flow cytometry were utilized to test viability and apoptosis. ELISA assay was utilized to estimate the IL-6 and TNF-α secretion. Western blot was performed to examine the expression of apoptosis and inflammation-associated mediators. After that HK-2 cells were transfected by miR-124 inhibitor. And the above-mentioned parameters were reassessed. LPS stimulated apoptosis and declined viability in HK-2 cells. Additionally, LPS stimulated inflammatory responses. Meanwhile, Quercetin attenuated LPS-stimulated apoptosis, production of IL-6, and TNF-α in experimental cells. Subsequently, MyD88 and miR-124 expression was elevated by LPS and alleviated by Quercetin. Finally, Quercetin exerted its protective function through NF-κB pathway via up-regulating miR-124. Our data demonstrated that Quercetin reduced apoptosis and inflammation stimulated by LPS in HK-2 cells. Moreover, Quercetin alleviated LPS-stimulated injury by up-regulating miR-124.
© 2019 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  Quercetin; apoptosis; chronic kidney disease; inflammatory responses; miR-124

Mesh:

Substances:

Year:  2019        PMID: 31804760     DOI: 10.1002/biof.1596

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.438


  6 in total

1.  Network Pharmacology and In Vivo Analysis of Dahuang-Huangqi Decoction Effectiveness in Alleviating Renal Interstitial Fibrosis.

Authors:  Yan Luo; Chen Xuan; Junxiong Cheng; Yu Xiong; Wenfu Cao
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-25       Impact factor: 2.650

2.  A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease.

Authors:  Xue-Feng Zhou; Wei-E Zhou; Wen-Jing Liu; Min-Jing Luo; Xia-Qing Wu; Ying Wang; Peng Liu; Yu-Min Wen; Jia-Lin Li; Ting-Ting Zhao; Hao-Jun Zhang; Hai-Ling Zhao; Ping Li
Journal:  J Transl Int Med       Date:  2021-06-18

3.  Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?

Authors:  Zhenjie Zhuang; Junmao Wen; Lu Zhang; Mingjia Zhang; Xiaoying Zhong; Huiqi Chen; Chuanjin Luo
Journal:  Eur J Integr Med       Date:  2020-05-26       Impact factor: 1.314

4.  Molecular Mechanisms Underlying Protective Role of Quercetin on Copper Sulfate-Induced Nephrotoxicity in Mice.

Authors:  Xinyan Peng; Chongshan Dai; Min Zhang; Subhajit Das Gupta
Journal:  Front Vet Sci       Date:  2021-01-08

Review 5.  Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.

Authors:  Michel Desjarlais; Maëlle Wirth; Isabelle Lahaie; Pakiza Ruknudin; Pierre Hardy; Alain Rivard; Sylvain Chemtob
Journal:  Front Pharmacol       Date:  2020-12-11       Impact factor: 5.810

Review 6.  Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines.

Authors:  Yi-Qin Chen; Hao-Yin Chen; Qin-Qi Tang; Yi-Fan Li; Xu-Sheng Liu; Fu-Hua Lu; Yue-Yu Gu
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.